GROWTH HORMONE RELEASING FACTOR ANALOGS AND PROCESS THEREFORE

Novel growth hormone releasing factor analogs in which glycine at position 15 is replaced by alanine, leucine, valine, isoleucine, norleucine, norvaline, β-alanine or a -aminoisobutyric acid and pharmaceutical compositions containing them demonstrate enhanced potency for the release of growth hormon...

Full description

Saved in:
Bibliographic Details
Main Authors FELIX, ARTHUR MARTIN, HEIMER, EDGAR P, MOWLES, THOMAS F
Format Patent
LanguageEnglish
Published 15.04.1992
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Novel growth hormone releasing factor analogs in which glycine at position 15 is replaced by alanine, leucine, valine, isoleucine, norleucine, norvaline, β-alanine or a -aminoisobutyric acid and pharmaceutical compositions containing them demonstrate enhanced potency for the release of growth hormone and can be administered to humans suffering from a deficiency of growth hormone and to animals in order to promote their growth.
Bibliography:Application Number: EP19850111959